Fact CheckerSign in

NCT01678027Active, not recruitingPhase 3

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

Helicobacter Pylori Eradication to Prevent Gastric Cancer in Subjects With Family History of Gastric Cancer: A Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 9 Nov 2023

Brief summary (registry, in English)

This study evaluate whether treatment of Helicobacter pylori infection reduces the incidence of gastric cancer in subjects with family history of gastric cancer.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
1838 (actual)
First submitted
17 Aug 2012
Start date
Nov 2004
Primary completion date
Dec 2018
Lead sponsor
National Cancer Center, Korea
NCT number
NCT01678027

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 1838
  • From Nov 2004 to the primary completion date, Dec 2018
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous serious side effect to antibiotics
  • Serious concurrent infection or nonmalignant disease such as liver cirrhosis, renal failure, cardiovascular diseases

Other illness

  • Gastric cancer history
  • Other malignancy within the past 5 years
  • Hereditary cancer family member (HNPCC, FAP)
  • Peptic ulcer history
  • Peptic ulcer, esophageal cancer, gastric cancer case found at EGD
  • Psychiatric disorder that would preclude compliance, alcoholics

Other

  • H. pylori eradication treatment history
  • Pregnant or nursing women
  • Refuse informed consent

Who the study is looking for

  • Sibling or offspring of patients with gastric adenocarcinoma confirmed by EGD and biopsy
  • Informed consent should be signed

Age in the registry: 40 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Cancer Center - Korea
Coordinator of this site? Confirm its status
Goyang-siSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.